IRF3 and neoplasm: Furthermore, tumor-derived DNA can be transferred and released into the cytosol of macrophages and DCs20, which in turn, activates cGAS-STING-IRF3-induced IFN signaling and enables DCs to present tumor-antigen and prime CD8+ T cells for anti-tumor immunity21.